DAS 28 in Belgium. Prof. F. De Keyser. Introduction of DAS 28 in Belgian rheumatology. Background RTX reimbursement since June 2007 K55 nomenclature since Feb. 2009 1) Why the DAS 28 ? 2) Which cut-off should alert for a change in therapy? 3) Rituximab and DAS 28. 1) Why DAS 28 ?.
Prof. F. De Keyser
1) Why the DAS 28 ?
2) Which cut-off should alert for a change in therapy?
3) Rituximab and DAS 28
Because DAS 28 best correlates with the expert’s satisfaction about control of disease activity
A cut-off value provides a good balance between sensitivity and specificity for change of therapy
Belgian criteria for rituximab retreatment in RA patients failed on anti-TNF
DAS 28 response (w16)
DAS 28 ≥ 3.2